BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 32463172)

  • 1. Sirtuin 3 is essential for hypertension-induced cardiac fibrosis via mediating pericyte transition.
    Su H; Zeng H; Liu B; Chen JX
    J Cell Mol Med; 2020 Jul; 24(14):8057-8068. PubMed ID: 32463172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SIRT3 Deficiency Sensitizes Angiotensin-II-Induced Renal Fibrosis.
    Feng X; Su H; He X; Chen JX; Zeng H
    Cells; 2020 Nov; 9(11):. PubMed ID: 33233553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SIRT3 blocks myofibroblast differentiation and pulmonary fibrosis by preventing mitochondrial DNA damage.
    Bindu S; Pillai VB; Kanwal A; Samant S; Mutlu GM; Verdin E; Dulin N; Gupta MP
    Am J Physiol Lung Cell Mol Physiol; 2017 Jan; 312(1):L68-L78. PubMed ID: 27815257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blockage of AKAP12 accelerates angiotensin II (Ang II)-induced cardiac injury in mice by regulating the transforming growth factor β1 (TGF-β1) pathway.
    Li Y; Yu QH; Chu Y; Wu WM; Song JX; Zhu XB; Wang Q
    Biochem Biophys Res Commun; 2018 May; 499(2):128-135. PubMed ID: 29501491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transforming growth factor β-1 stimulates profibrotic epithelial signaling to activate pericyte-myofibroblast transition in obstructive kidney fibrosis.
    Wu CF; Chiang WC; Lai CF; Chang FC; Chen YT; Chou YH; Wu TH; Linn GR; Ling H; Wu KD; Tsai TJ; Chen YM; Duffield JS; Lin SL
    Am J Pathol; 2013 Jan; 182(1):118-31. PubMed ID: 23142380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LPS causes pericyte loss and microvascular dysfunction via disruption of Sirt3/angiopoietins/Tie-2 and HIF-2α/Notch3 pathways.
    Zeng H; He X; Tuo QH; Liao DF; Zhang GQ; Chen JX
    Sci Rep; 2016 Feb; 6():20931. PubMed ID: 26868537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac Pericytes Acquire a Fibrogenic Phenotype and Contribute to Vascular Maturation After Myocardial Infarction.
    Alex L; Tuleta I; Hernandez SC; Hanna A; Venugopal H; Astorkia M; Humeres C; Kubota A; Su K; Zheng D; Frangogiannis NG
    Circulation; 2023 Sep; 148(11):882-898. PubMed ID: 37350296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sirtuin 3 Deficiency Accelerates Hypertensive Cardiac Remodeling by Impairing Angiogenesis.
    Wei T; Huang G; Gao J; Huang C; Sun M; Wu J; Bu J; Shen W
    J Am Heart Assoc; 2017 Aug; 6(8):. PubMed ID: 28862956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of Endothelial-to-Mesenchymal Transition by SIRT (Sirtuin) 3 Alleviated the Development of Hypertensive Renal Injury.
    Lin JR; Zheng YJ; Zhang ZB; Shen WL; Li XD; Wei T; Ruan CC; Chen XH; Zhu DL; Gao PJ
    Hypertension; 2018 Aug; 72(2):350-360. PubMed ID: 29915018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sirt3 promotes sensitivity to sunitinib-induced cardiotoxicity via inhibition of GTSP1/JNK/autophagy pathway in vivo and in vitro.
    Yang Y; Li N; Chen T; Zhang C; Li J; Liu L; Qi Y; Zheng X; Zhang C; Bu P
    Arch Toxicol; 2019 Nov; 93(11):3249-3260. PubMed ID: 31552474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sirtuin 3 deficiency aggravates angiotensin II-induced hypertensive cardiac injury by the impairment of lymphangiogenesis.
    Zhang C; Li N; Suo M; Zhang C; Liu J; Liu L; Qi Y; Zheng X; Xie L; Hu Y; Bu P
    J Cell Mol Med; 2021 Aug; 25(16):7760-7771. PubMed ID: 34180125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin II upregulates fibroblast-myofibroblast transition through Cx43-dependent CaMKII and TGF-β1 signaling in neonatal rat cardiac fibroblasts.
    Cao L; Chen Y; Lu L; Liu Y; Wang Y; Fan J; Yin Y
    Acta Biochim Biophys Sin (Shanghai); 2018 Sep; 50(9):843-852. PubMed ID: 30060053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apelin gene therapy increases myocardial vascular density and ameliorates diabetic cardiomyopathy via upregulation of sirtuin 3.
    Zeng H; He X; Hou X; Li L; Chen JX
    Am J Physiol Heart Circ Physiol; 2014 Feb; 306(4):H585-97. PubMed ID: 24363305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin-(1-7) attenuates angiotensin II-induced cardiac hypertrophy via a Sirt3-dependent mechanism.
    Guo L; Yin A; Zhang Q; Zhong T; O'Rourke ST; Sun C
    Am J Physiol Heart Circ Physiol; 2017 May; 312(5):H980-H991. PubMed ID: 28411231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin II type 2 receptor is essential for left ventricular hypertrophy and cardiac fibrosis in chronic angiotensin II-induced hypertension.
    Ichihara S; Senbonmatsu T; Price E; Ichiki T; Gaffney FA; Inagami T
    Circulation; 2001 Jul; 104(3):346-51. PubMed ID: 11457756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNA GAS5 suppresses TGF-β1-induced transformation of pulmonary pericytes into myofibroblasts by recruiting KDM5B and promoting H3K4me2/3 demethylation of the PDGFRα/β promoter.
    Wang Y; Chen D; Xie H; Zhou S; Jia M; He X; Guo F; Lai Y; Tang XX
    Mol Med; 2023 Mar; 29(1):32. PubMed ID: 36918759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Klotho inhibits angiotensin II-induced cardiac hypertrophy, fibrosis, and dysfunction in mice through suppression of transforming growth factor-β1 signaling pathway.
    Ding J; Tang Q; Luo B; Zhang L; Lin L; Han L; Hao M; Li M; Yu L; Li M
    Eur J Pharmacol; 2019 Sep; 859():172549. PubMed ID: 31325434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-fat diet induces cardiac remodelling and dysfunction: assessment of the role played by SIRT3 loss.
    Zeng H; Vaka VR; He X; Booz GW; Chen JX
    J Cell Mol Med; 2015 Aug; 19(8):1847-56. PubMed ID: 25782072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paricalcitol Improves Hypoxia-Induced and TGF-β1-Induced Injury in Kidney Pericytes.
    Lim JH; Yook JM; Oh SH; Jeon SJ; Noh HW; Jung HY; Choi JY; Cho JH; Kim CD; Kim YL; Park SH
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34575914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-214 contributes to Ang II-induced cardiac hypertrophy by targeting SIRT3 to provoke mitochondrial malfunction.
    Ding YQ; Zhang YH; Lu J; Li B; Yu WJ; Yue ZB; Hu YH; Wang PX; Li JY; Cai SD; Ye JT; Liu PQ
    Acta Pharmacol Sin; 2021 Sep; 42(9):1422-1436. PubMed ID: 33247214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.